Nepafenac
CAS No. 78281-72-8
Nepafenac ( AHR-9434;AL-6515 )
Catalog No. M15955 CAS No. 78281-72-8
A nonsteroidal anti-inflammatory drug (NSAID) that inhibits COX-1 and COX-2 activity; a prodrug of amfenac.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
25MG | 41 | In Stock |
|
100MG | 109 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNepafenac
-
NoteResearch use only, not for human use.
-
Brief DescriptionA nonsteroidal anti-inflammatory drug (NSAID) that inhibits COX-1 and COX-2 activity; a prodrug of amfenac.
-
DescriptionA nonsteroidal anti-inflammatory drug (NSAID) that inhibits COX-1 and COX-2 activity; a prodrug of amfenac.Other Indication Approved
-
SynonymsAHR-9434;AL-6515
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX-1;COX-2
-
Research AreaOther Indications
-
IndicationOther Disease
Chemical Information
-
CAS Number78281-72-8
-
Formula Weight254.28
-
Molecular FormulaC15H14N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 32 mg/mL
-
SMILESO=C(N)CC1=CC=CC(C(C2=CC=CC=C2)=O)=C1N
-
Chemical NameBenzeneacetamide, 2-amino-3-benzoyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Gamache DA, et al. Inflammation. 2000 Aug;24(4):357-70.
2. Singh RP, et al. Ophthalmology. 2017 Jun;124(6):776-785.
3. Abu Hussein NB, et al .J Ophthalmol. 2017;2017:3765253.
2. Singh RP, et al. Ophthalmology. 2017 Jun;124(6):776-785.
3. Abu Hussein NB, et al .J Ophthalmol. 2017;2017:3765253.
molnova catalog
related products
-
beta-Amyrone
beta-Amyrone has antifungal activity against Chikungunya virus replication with an EC50 of 86 uM. beta-Amyrone has anti-inflammatory activity through inhibiting the expression of COX-2. beta-Amyrone exhibits anti-α-glucosidase inhibitory activity and moderate AChE activity. β-Amyrone can be used in the research of disease like inflammation, infection, and obesity.
-
Pamicogrel
Pamicogrel is an inhibitor of COX. Pamicogrel has platelet anti-aggregatory properties which is under development by Kanebo for chronic arterial occlusion.
-
Diclofenac sodium
Diclofenac Sodium is a non-selective COX inhibitor with IC50 of 60 and 220 nM for ovine COX-1 and -2, respectively.